NFKB1 and ovarian cancer: In ovarian cancer, NF-κB transcriptionally upregulates HOTAIR expression during cisplatin-induced DNA damage, and HOTAIR facilitates degradation of the NF-κB inhibitor IκBα and thus enhances NF-κB activation, thereby creating a feed-forward regulatory circuit between NF-κB and HOTAIR [25].